Relative Strength Chart Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart Other stock markets 15:56:28 2026-07-17 EDT			5-day change	1st Jan Change
0.1450 ^EUR	+11.54%		-9.38%	-29.61%

07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
05-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	NORTHWEST BIOTHERAPEUTICS, INC.	Bio Therapeutic Drugs	+11.54%	-9.38%	-29.61%	-30.29%	-86.06%	280M	-	-	-